Silence Therapeutics (SLN) Revenue (2020 - 2025)
Historic Revenue for Silence Therapeutics (SLN) over the last 6 years, with Q3 2025 value amounting to $159000.0.
- Silence Therapeutics' Revenue fell 8938.58% to $159000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $25.8 million, marking a year-over-year increase of 2537.51%. This contributed to the annual value of $43.3 million for FY2024, which is 3670.64% up from last year.
- According to the latest figures from Q3 2025, Silence Therapeutics' Revenue is $159000.0, which was down 8938.58% from $224000.0 recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Revenue registered a high of $25.3 million during Q4 2024, and its lowest value of -$12133.4 billion during Q4 2021.
- In the last 5 years, Silence Therapeutics' Revenue had a median value of $3.8 million in 2021 and averaged -$638.6 billion.
- In the last 5 years, Silence Therapeutics' Revenue tumbled by 16780644790.2% in 2021 and then surged by 17700275.93% in 2022.
- Quarter analysis of 5 years shows Silence Therapeutics' Revenue stood at -$12133.4 billion in 2021, then soared by 100.0% to $5.6 million in 2022, then plummeted by 53.39% to $2.6 million in 2023, then soared by 871.33% to $25.3 million in 2024, then plummeted by 99.37% to $159000.0 in 2025.
- Its Revenue stands at $159000.0 for Q3 2025, versus $224000.0 for Q2 2025 and $142000.0 for Q1 2025.